# Evaluation of Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.

> **NCT00150293** · PHASE3 · COMPLETED · sponsor: **Pfizer** · enrollment: 337 (—)

## Conditions studied

- Seizure Disorder, Partial

## Interventions

- **DRUG:** Pregabalin

## Key facts

- **NCT ID:** NCT00150293
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-03
- **Primary completion:** —
- **Final completion:** 2005-11
- **Target enrollment:** 337 (—)
- **Last updated:** 2015-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00150293

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00150293, "Evaluation of Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00150293. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*